Английская Википедия:Iomazenil

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description

Шаблон:Drugbox

Iomazenil (also known as Ro16-0154, INN, USAN; benzodine) is an antagonist and partial inverse agonist of benzodiazepine and a potential treatment for alcohol use disorder. The compound was introduced in 1989 by pharmaceutical company Hoffmann-La Roche as an Iodine-123-labelled SPECT tracer for imaging benzodiazepine receptors (GABAA receptors) in the brain. Iomazenil is an analogue of flumazenil (Ro15-1788).[1]

Use in brain research

123I-labelled iomazenil can be used to image epileptic seizure foci as an alternative to 18F-fludeoxyglucose PET imaging.[2][3]

The effect of iomazenil of reducing levels of GABA in the brain was used by researchers to exacerbate symptoms in patients with schizophrenia in a laboratory study, supporting the theory that a GABA deficiency underlies that disease.[4]

Alcohol treatment

Researchers at Yale University and Veterans Affairs Connecticut Healthcare System have been testing iomazenil as a potential treatment for drunkenness due to its ability to bind alcohol receptors in the brain.[5]

See also

References

Шаблон:Reflist

External links

Шаблон:Refbegin

Шаблон:Refend

Шаблон:Diagnostic radiopharmaceuticals Шаблон:GABA receptor modulators Шаблон:Benzodiazepines